Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways
- 6 October 2006
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 46 (2), 222-229
- https://doi.org/10.1016/j.jhep.2006.08.012
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Transforming growth factor-β inhibition of proteasomal activity: a potential mechanism of growth arrestAmerican Journal of Physiology-Cell Physiology, 2003
- Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell linesBritish Journal of Cancer, 2003
- Inhibition of Cholangiocarcinoma Growth by Tannic AcidHepatology, 2003
- Changing international trends in mortality rates for liver, biliary and pancreatic tumoursJournal of Hepatology, 2002
- Worldwide trends in mortality from biliary tract malignanciesBMC Cancer, 2002
- Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epitheliaGastroenterology, 2001
- Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United StatesHepatology, 2001
- Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998Gut, 2001
- Molecular identification and functional characterization of Mdr1a in rat cholangiocytesGastroenterology, 2000
- Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell lineHepatology, 1999